Amicus Therapeutics Inc (FOLD) Return on Investment ROI from the fourth quarter of 2025 to fourth quarter of 2024 and for the year 2025, average high and low, overall ranking from Dec 31 2025 to Dec 31 2024 - CSIMarket
CSIMarket Company Name, Ticker, Suppliers, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Amicus Therapeutics inc   (NASDAQ: FOLD)


Amicus Therapeutics Inc's ROI from its fourth quarter of 2025 to the fourth quarter of 2024 and 5 Year Period

Return on Investment, Quarterly Results, Trends, Rankings, Statistics

What is Amicus Therapeutics Inc's ROI in the fourth quarter of 2025?
Amicus Therapeutics Inc recorded a cumulative net loss of $-27 million during 12 months ending in the fourth quarter of 2025, resulting in a negative return on investment (ROI) of -4.07%.

Within the Healthcare sector 156 other companies had a higher return on investment. While Return on investment, overall ranking has progressed in the Dec 31 2025 quarter, so far to 1837, from total ROI ranking in the third quarter of 2025 at 2377.

Definition and Formula of Return on Investment


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Investment (Dec 31 2025)
IV. Quarter		 (Sep 30 2025)
III. Quarter		 (Jun 30 2025)
II. Quarter		 (Mar 31 2025)
I. Quarter		 (Dec 31 2024)
IV. Quarter
Y / Y Investment Change TTM 9.92 % 7.96 % 7.75 % 5.42 % 3.77 %
Y / Y Net Income Change TTM - - - - -
Investment (TTM) in Millions 712 670 648 637 636
Return On Investment (TTM) -4.07 % -2.17 % -5.98 % -4.73 % -9.25 %
FOLD's Overall Ranking # 1837 # 2377 # 2368 # 2258 # 1985
Seq. Investment Change TTM 2.92 % 1.63 % 2.67 % 2.36 % 1.09 %
Seq. Net Income Change TTM - - - - -
Net Income (TTM) in Millions -27 -14 -38 -29 -56

FOLD Company Profile >> Back to FOLD Roi Comparisons >> See Annual FOLD Return On Investment



Return On Investment FOLD's Ranking
Within: No.
Industry # 57
Sector # 157
Overall # 1837

Return On Investment Statistics
High Average Low
-2.17 %
-33.19 %
-60.86 %
(Sep 30 2025)   (Jun 30 2019)







Financial Statements
Amicus Therapeutics Inc's IV. Quarter Investments $ 712 Millions FOLD's Balance sheet
Amicus Therapeutics Inc's IV. Quarter Income $ 2 Millions Quarterly FOLD's Income Statement
FOLD's Income by Division See FOLD's Income by Division


FOLD Annual Return On Investment (Dec 31 2025)
2025		 (Dec 31 2024)
2024		 (Dec 31 2023)
2023		 (Dec 31 2022)
2022		 (Dec 31 2021)
2021
Total Investments in Millions 712 636 610 585 759
Y / Y Investment Growth 11.9 % 4.28 % 4.28 % -22.92 % 0.31 %
Net Income in Millions -27 -56 -152 -237 -250
Y / Y Net Income Growth - - - - -
Annual Return On Investment -3.81 % -8.82 % -24.84 % -40.43 % -32.99 %


Annual Roi Comment


Definition and Formula of Return on Investment

Other ROI Ratios
Major Pharmaceutical Preparations Industry Roi Trends and Statistics
Healthcare Sector Return On Investment Statistics
Roi Trends for overall market
FOLD's Roi Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Return On Investment
Lowest Ranking Return On Investment
Subscribers only: Roi for FOLD's Competitors
Subscribers only: Roi for Amicus Therapeutics Inc's Suppliers
Subscribers only: Return On Investment for FOLD's Customers

Other Ratios
FOLD's Roa FOLD's Inventory Turnover Ratio FOLD's Growth Rates FOLD's Dividend Statistics
FOLD's Profitability Ratios FOLD's Asset Turnover Ratio FOLD's Dividend Growth
FOLD's Roe FOLD's Valuation Ratios FOLD's Financial Strength Ratios FOLD's Dividend Payout Ratio



Companies with similar Return On Investment at Dec 31 2025, within Healthcare Sector ROI

Date modified: 2026-06-22T14:32:45+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.